首頁 > 市場調查報告書 > 醫療設備

e保健遠距離醫療

市場調查報告書

商品編碼

1678797

日本遠距醫療市場 - 2025 - 2033

Japan Telemedicine Market - 2025-2033

出版日期: 2025年03月11日 | 出版商:

DataM Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年日本遠距醫療市場規模達到 51.4291 億美元，預計到 2033 年將達到 258.6749 億美元，2025-2033 年預測期內的複合年成長率為 19.5%。

遠距醫療是一種遠距醫療服務方式，利用電信技術為患者提供醫療建議、診斷和治療計畫。它解決了醫療保健獲取方面的障礙，如地理距離、時間限制和患者流動性問題。遠距醫療對於醫療保健人員短缺的農村地區尤其有益。隨著科技的進步，遠距醫療融合了遠端監控、人工智慧診斷和行動健康專業領域等工具，成為數位醫療革命的關鍵部分。

市場動態：

促進因素與約束因素

日本人口老化和遠距醫療需求不斷成長

日本遠距醫療市場受到人口老化和遠距醫療需求不斷成長的推動。日本65歲以上的人口比例大，糖尿病、高血壓、心血管病等慢性病發生率都很高。遠距醫療提供了一種便捷的解決方案，特別是對於偏遠地區的老年人來說。遠端諮詢和監控系統彌合了患者和醫療保健提供者之間的差距，確保及時護理並減少醫院就診次數。對遠距醫療的依賴不斷增加，推動了日本市場的成長。

例如，日本的住院護理需求預計將在2040年達到峰值，從而導致醫療和福利工作者在2035-2040年間成為最大的產業。預計2040年醫療衛生支出將達到89兆日圓，比2023年高出1.6倍，造成27兆日圓的財政缺口。為了維持現有的醫療保健水平，政府可能需要減少低價值護理，將任務從醫生轉移到其他職業，並透過數位轉型提高效率。

監管挑戰和資料隱私問題

由於嚴格的醫療保健法規，日本遠距醫療市場面臨監管挑戰和資料隱私問題。雖然遠距醫療可以改善醫療服務，但這些規定限制了數位健康解決方案的廣泛採用。遠距醫療平台必須遵守病患保密、資料安全和許可要求。確保個人健康資料的安全傳輸和儲存是一個主要問題，尤其是在網路安全威脅日益加劇的情況下。這種複雜的監管環境可能會減緩日本遠距醫療服務的成長。

Telemedicine is a remote healthcare delivery method that uses telecommunications technology to provide medical advice, diagnoses, and treatment plans to patients. It addresses barriers to healthcare access like geographical distance, time constraints, and patient mobility issues. Telemedicine is particularly beneficial in rural areas with healthcare workforce shortages. As technology advances, telemedicine incorporates tools like remote monitoring, AI-driven diagnostics, and mobile health Speciality Areas, making it a key part of the digital healthcare revolution.

Market Dynamics: Drivers & Restraints

Aging Population and Rising Remote Healthcare Demand in Japan

The Japan telemedicine market is driven by the aging population and increasing demand for remote healthcare. With a significant percentage of the population aged 65 and above, Japan is facing a high incidence of chronic conditions like diabetes, hypertension, and cardiovascular diseases. Telemedicine offers a convenient solution, especially for elderly individuals in remote areas. Remote consultations and monitoring systems bridge the gap between patients and healthcare providers, ensuring timely care and reducing hospital visits. This increased reliance on telemedicine is driving market growth in Japan.

For instance, Japan's inpatient care demand is expected to peak by 2040, leading to medical and welfare workers becoming the largest industry by 2035-2040. Healthcare expenditures in 2040 are projected to reach ¥89 trillion, 1.6 times higher than in 2023, causing a ¥27 trillion financial shortfall. To maintain current medical care levels, the government may need to reduce low-value care, shift tasks from physicians to other professions, and improve efficiency through digital transformation.

Regulatory Challenges and Data Privacy Concerns

The Japan telemedicine market faces regulatory challenges and data privacy concerns due to strict healthcare regulations. While telemedicine can improve healthcare access, these regulations limit the widespread adoption of digital health solutions. Telemedicine platforms must comply with patient confidentiality, data security, and licensing requirements. Ensuring secure transmission and storage of personal health data is a major concern, especially amid rising cybersecurity threats. This complex regulatory landscape could slow telemedicine service growth in Japan.

Segment Analysis

The Japan telemedicine market is segmented based on type, specialty area, and end user

Type:

mHealth in the type segment is expected to dominate with the highest market share

Mobile health (mHealth) is a key in Japan's telemedicine landscape, enhancing accessibility, efficiency, and patient engagement. It enables remote monitoring, virtual consultations, and chronic disease management through smartphones and wearable devices. It supports the aging population by enabling real-time health tracking and medication adherence. mHealth integrates with EHRs and AI for improved diagnostic accuracy and personalized treatment plans. Government initiatives and regulatory support drive its expansion.

End User:-

Hospitals are expected to dominate the end-user segment with the highest market share.

The hospital segment is the fastest-growing segment in the telemedicine market share and is expected to hold the market share over the forecast period.

Japan's hospitals are integrating digital health solutions into their services, particularly in rural areas with limited resources. They are using telemedicine platforms to provide remote consultations, specialist access, and follow-up care to patients who cannot visit in person. This reduces wait times and alleviates pressure on staff and infrastructure. Telemedicine is also being used to improve patient monitoring for chronic conditions. As Japan's healthcare system transitions towards patient-centered care, telemedicine is being increasingly adopted to enhance efficiency, reduce readmissions, and improve patient outcomes.

Competitive Landscape

The major country players in the Telemedicine market include Nihon Kohden Corporation, MEDLEY, INC, Terumo Corporation, M3, Inc, Medmain, PK Telehealth, NTT Data Inc, Sony Corporation, and others.

Key Developments

In April 2024, Japan's internal affairs ministry launched an initiative to offer online doctor consultations and medication guidance through private booths at post offices, with drugs delivered via postal service.
In June 2024, Infosys partnered with Japan's dispensing pharmacy chain, Nihon Chouzai, to improve healthcare access in Japan. The partnership includes the development of a mobile application, NiCOMS, which offers remote medication guidance from registered pharmacists, eliminating the need for pharmacy visits.

Why Purchase the Report?

Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth countries and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.

The Japan Telemedicine market report delivers a detailed analysis with 33 key tables, more than 27 visually impactful figures, and 140 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Speciality Area & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Specialty Area
3.3. Snippet by End User

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Aging Population and Rising Remote Healthcare Demand in Japan
- 4.1.2. Restraints
  - 4.1.2.1. Regulatory Challenges and Data Privacy Concerns
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. mHealth*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Tele Hospitals/Clinics
6.4. Telehome

7. By Specialty Area

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specialty Area
- 7.1.2. Market Attractiveness Index, By Specialty Area
7.2. Dermatology*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cardiology
7.4. Gynecology
7.5. Psychiatry
7.6. Trauma Care
7.7. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinics
8.4. Others

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

10.1. Nihon Kohden Corporation*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio
  - 10.1.2.1. Product Description
  - 10.1.2.2. Product Key Performance Indicators (KPIs)
  - 10.1.2.3. Historic and Forecasted Product Sales
  - 10.1.2.4. Product Sales Volume
- 10.1.3. Financial Overview
  - 10.1.3.1. Company Revenue's
  - 10.1.3.2. Geographical Revenue Shares
  - 10.1.3.3. Revenue Forecasts
- 10.1.4. Key Developments
  - 10.1.4.1. Mergers & Acquisitions
  - 10.1.4.2. Key Product Development Activities
  - 10.1.4.3. Regulatory Approvals, etc.
- 10.1.5. SWOT Analysis
10.2. MEDLEY, INC
10.3. Terumo Corporation
10.4. M3, Inc
10.5. Medmain
10.6. PK Telehealth
10.7. NTT Data Inc
10.8. Sony Corporation
Similar data will be provided for each market player.